FDA advisers back Pfizer’s COVID-19 vaccine for children ages 5-11
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 shot, moving the U.S. closer to beginning vaccinations in children ages 5-11.
Video transcript
[MUSIC PLAYING]